LUPINI, Laura
 Distribuzione geografica
Continente #
NA - Nord America 5.317
AS - Asia 2.359
EU - Europa 1.860
SA - Sud America 311
Continente sconosciuto - Info sul continente non disponibili 105
AF - Africa 53
OC - Oceania 3
Totale 10.008
Nazione #
US - Stati Uniti d'America 5.163
SG - Singapore 877
CN - Cina 572
IT - Italia 476
DE - Germania 294
VN - Vietnam 281
PL - Polonia 273
BR - Brasile 230
FI - Finlandia 189
HK - Hong Kong 175
GB - Regno Unito 167
TR - Turchia 132
UA - Ucraina 103
CA - Canada 80
SE - Svezia 68
FR - Francia 62
BD - Bangladesh 57
IN - India 53
JP - Giappone 49
ID - Indonesia 45
MX - Messico 43
RU - Federazione Russa 43
NL - Olanda 33
BE - Belgio 31
AR - Argentina 27
RO - Romania 21
CZ - Repubblica Ceca 19
ZA - Sudafrica 19
IQ - Iraq 18
AT - Austria 16
ES - Italia 15
CO - Colombia 13
PK - Pakistan 13
LT - Lituania 12
IE - Irlanda 10
MY - Malesia 10
CL - Cile 9
CR - Costa Rica 9
EC - Ecuador 9
TN - Tunisia 9
VE - Venezuela 9
EG - Egitto 8
IR - Iran 7
PH - Filippine 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
JM - Giamaica 6
PE - Perù 6
BO - Bolivia 5
DZ - Algeria 5
KE - Kenya 5
KZ - Kazakistan 5
OM - Oman 5
AL - Albania 4
EE - Estonia 4
JO - Giordania 4
NP - Nepal 4
AU - Australia 3
GR - Grecia 3
LV - Lettonia 3
MA - Marocco 3
NI - Nicaragua 3
TW - Taiwan 3
BH - Bahrain 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
HN - Honduras 2
IL - Israele 2
KR - Corea 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LK - Sri Lanka 2
NO - Norvegia 2
PA - Panama 2
PY - Paraguay 2
QA - Qatar 2
TT - Trinidad e Tobago 2
AD - Andorra 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
EU - Europa 1
GD - Grenada 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
KY - Cayman, isole 1
LU - Lussemburgo 1
MN - Mongolia 1
MQ - Martinica 1
MT - Malta 1
PS - Palestinian Territory 1
RS - Serbia 1
Totale 9.898
Città #
Ashburn 663
Singapore 523
Fairfield 430
San Jose 373
Woodbridge 350
Warsaw 271
Houston 230
Ann Arbor 223
Beijing 216
Chandler 203
Santa Clara 186
Seattle 178
Hong Kong 174
Munich 171
Cambridge 135
Council Bluffs 133
Wilmington 129
Jacksonville 126
New York 118
Ferrara 114
Helsinki 113
Dallas 112
Ho Chi Minh City 95
Los Angeles 81
Izmir 66
Milan 64
Hanoi 53
Tokyo 49
Turku 47
Shanghai 46
Nanjing 45
Princeton 38
Jakarta 36
Orem 36
Phoenix 35
Lauterbourg 34
Brussels 31
Rome 30
Chicago 29
London 29
Buffalo 28
Boardman 27
Mexico City 27
San Diego 27
Atlanta 25
Tianjin 23
São Paulo 22
Toronto 22
Denver 21
Montreal 21
Nanchang 21
Bologna 19
Bremen 19
Brooklyn 19
The Dalles 19
Addison 17
Da Nang 17
Timisoara 17
Falls Church 16
Amsterdam 14
Chennai 14
Johannesburg 14
Washington 14
Brno 13
Dong Ket 13
Shenyang 13
Changsha 12
Haiphong 12
Manchester 12
Nuremberg 12
Boston 11
San Francisco 11
Stockholm 11
Dublin 10
Naples 10
Poplar 10
Redwood City 10
Rio de Janeiro 10
Charlotte 9
Dearborn 9
Hebei 9
Moscow 9
Barnet 8
Columbus 8
Frankfurt am Main 8
Kunming 8
San José 8
Philadelphia 7
Santiago 7
Ankara 6
Auburn Hills 6
Baghdad 6
Belo Horizonte 6
Falkenstein 6
Hangzhou 6
Hefei 6
Jiaxing 6
Mountain View 6
Salt Lake City 6
Tampa 6
Totale 6.804
Nome #
Absolute quantification of cell-free microRNAs in cancer patients 355
A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma 337
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 330
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 324
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 316
High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy 315
Ruolo del miR-221 nella tumorigenesi epatica 296
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 295
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 289
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 289
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 277
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 267
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 266
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 261
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 260
Downregulation of the mitochondrial calcium uniporter by cancer-related miR-25 257
Circulating non-coding RNA as biomarkers in colorectal cancer 249
HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights 246
Quantification of circulating miRNAs by droplet digital PCR: Comparison of EvaGreen- and TaqMan-based chemistries 242
Circulating microRNA quantification using DNA-binding dye chemistry and droplet digital PCR 239
Circulating tumor DNAs and non-coding RNAs as potential biomarkers for hepatocellular carcinoma diagnosis, prognosis and response to therapy 239
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 237
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 233
Estrogen receptor mutation: a new strategy to overcome endocrine resistance 228
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 222
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 221
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer 209
Mutated beta-catenin evades a microRNA-dependent regulatory loop 204
Molecular biomarkers predicting early development of endometrial carcinoma: A pilot study 203
MiR-145 participates with TP53 in a death promoting regulatory loop and targets estrogen receptor in human breast cancer cells 200
Inhibiting the oncogenic mir-221 by microRNA sponge: Toward microRNA-based therapeutics for hepatocellular carcinoma 190
Oncogenic role of miR-483-3p at the IGF2/483 locus 190
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study 189
Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy 180
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 179
Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients 177
MicroRNA Expression Profiling and Its Clinical Impact in Breast Cancer 172
The importance of microRNAs in RAS oncogenic activation in human cancer 167
Microbiota and environmental health monitoring of mouse colonies by metagenomic shotgun sequencing 157
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs 140
How to fish a good micro-marker out from a worthless lake: The case of cell-free miR-181a-5p and breast cancer 132
null 89
null 77
null 63
Totale 10.008
Categoria #
all - tutte 43.122
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.829
Totale 44.951


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022368 0 0 0 23 23 23 45 24 16 33 53 128
2022/2023474 48 41 29 67 66 72 35 31 52 2 17 14
2023/2024332 28 36 11 5 31 85 16 28 7 8 5 72
2024/20251.520 35 35 95 78 147 171 93 69 309 114 183 191
2025/20263.580 389 135 267 394 502 242 488 220 386 323 168 66
2026/2027743 89 166 363 125 0 0 0 0 0 0 0 0
Totale 10.008